Cardinal Capital Management Boosts Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Cardinal Capital Management boosted its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 9.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 75,010 shares of the company’s stock after purchasing an additional 6,568 shares during the period. Cardinal Capital Management’s holdings in Phibro Animal Health were worth $1,602,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Man Group plc purchased a new position in Phibro Animal Health in the fourth quarter valued at approximately $501,000. Lazard Asset Management LLC raised its holdings in Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock valued at $34,000 after acquiring an additional 1,589 shares during the period. Nuveen Asset Management LLC raised its holdings in Phibro Animal Health by 21.4% during the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock valued at $12,348,000 after acquiring an additional 103,618 shares during the period. Alliancebernstein L.P. raised its holdings in Phibro Animal Health by 357.1% during the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock valued at $2,730,000 after acquiring an additional 101,560 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Phibro Animal Health by 37.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 62,566 shares of the company’s stock valued at $1,314,000 after acquiring an additional 16,917 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on PAHC. BNP Paribas Exane raised shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 target price on the stock in a report on Monday. Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Finally, Morgan Stanley upped their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health presently has a consensus rating of “Hold” and a consensus price target of $20.80.

Phibro Animal Health Trading Up 3.3%

Phibro Animal Health stock opened at $24.71 on Tuesday. The stock has a market cap of $1.00 billion, a P/E ratio of 51.48, a PEG ratio of 0.45 and a beta of 0.74. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. Phibro Animal Health Co. has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The firm’s fifty day moving average price is $21.25 and its 200-day moving average price is $21.88.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million for the quarter, compared to analysts’ expectations of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities research analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.94%. Phibro Animal Health’s dividend payout ratio is presently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.